Vaccine Therapy in Treating Patients With Breast Cancer
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00524277|
Recruitment Status : Unknown
Verified November 2015 by COL George Peoples, MD, FACS, San Antonio Military Medical Center.
Recruitment status was: Active, not recruiting
First Posted : September 3, 2007
Last Update Posted : November 17, 2015
San Antonio Military Medical Center
Antigen Express, Inc.
Information provided by (Responsible Party):
COL George Peoples, MD, FACS, San Antonio Military Medical Center
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||December 2016|
|Estimated Study Completion Date :||December 2017|
Sears AK, Perez SA, Clifton GT, Benavides LC, Gates JD, Clive KS, Holmes JP, Shumway NM, Van Echo DC, Carmichael MG, Ponniah S, Baxevanis CN, Mittendorf EA, Papamichail M, Peoples GE. AE37: a novel T-cell-eliciting vaccine for breast cancer. Expert Opin Biol Ther. 2011 Nov;11(11):1543-50. doi: 10.1517/14712598.2011.616889. Epub 2011 Sep 6. Review.